It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

TREATING SINUSITIS

There are different treatments that help with sinusitis, depending on how serious the condition is and what caused it.1,2 The right choice of treatment will relieve your symptoms and prevent health complications.1

 

Acute (short-term) sinus infections are most often caused by a virus or bacteria.1 They normally get better on their own, but there are treatments available to help you manage the symptoms.1

For acute viral sinusitis:1

Congestions points

Acute viral sinusitis usually lasts less than 10 days, and symptoms should improve within 5 days.1

For acute bacterial sinusitis:

  • Milder infections can be treated with rest, hydration, warm facial packs, saline nasal sprays or other over-the-counter medications like mucolytics to relieve mucus congestion.3
  • In the case of a severe infection, your doctor may prescribe a course of antibiotics.1

For chronic sinusitis, it’s especially important to figure out the underlying cause of the problem.2 There isn’t any one “standard” or “correct” treatment plan.2 If you suffer from chronic sinusitis, it’s best to speak to your health care provider about finding the best treatment/s for you.2

References
  1. Acute sinusitis. BMJ Best Practice. August 19, 2021. Accessed September 20, 2021. https://bestpractice.bmj.com/topics/en-gb/14.
  2. Chronic sinusitis. BMJ Best Practice. August 4, 2020. Accessed September 20, 2021. https://bestpractice.bmj.com/topics/en-gb/15.
  3. Sandoz SA (Pty) Ltd. ACC® 200 Professional information. V10 (16/08/2022), approved 08 July 2020.
Sidebar References
  1. Sandoz SA (Pty) Ltd. ACC® 600 Professional information. V1.0 (02/11/2021), approved 26 October 2021 (oral powder) and 02 November 2021 (effervescent tablets).
  2. Sandoz SA (Pty) Ltd. ACC® 20 mg/ml ORAL SOLUTION Professional information. V1 (07/10/2021), approved 05 October 2021.
  3. Sandoz SA (Pty) Ltd. ACC® 200 Professional information. V10 (16/08/2022), approved 08 July 2020.

[S1] ACC® 20 mg/ml Oral Solution. Reg. No.: 48/10.3/0261. Composition: Each 1 ml of ACC 20 mg/ml ORAL SOLUTION contains 20 mg acetylcysteine. ATC Code: R05C B01.

[S1] ACC® 200 (effervescent tablets). Reg. No.: 29/10.2.2/0753. Composition: Each ACC 200 effervescent tablet contains: 200 mg acetylcysteine. Pharmacological Classification: A10.3 Medicines acting on the respiratory system – other.

[S1] ACC® 600 (effervescent tablets). Reg. No.: 45/10.3/0229. Composition: Each effervescent tablet contains 600 mg acetylcysteine. [S1] ACC® 600 ORAL POWDER. Reg. No.: 51/10.3/0816. Composition: Each sachet contains 600 mg of acetylcysteine. ATC Code: R05CB01.

For full prescribing information refer to the Sandoz Professional Information approved by the South African Health Products Regulatory Authority (SAHPRA).

Contact Us
Sandoz SA (Pty) Ltd, Reg. No. 1990/001979/07,
Magwa Crescent West,
Waterfall City,
Jukskei View,
Midrand,
2090.
Tel: +27 (11) 347 6600.
SANCAL Customer Call Centre: 0861 726 225.
Reporting of AEs: 
https://pvi1j.solutions.iqvia.com or [email protected]